In SKOV.CD19 ovarian tumor-bearing mice, the developed DDS CAR.NK.CLV could home to tumor sites and promote PTX accumulation within tumor niches, leading to significant tumor growth inhibition. This evidence concerns the gene CD19 and neoplasm.